Semaglutide

Semaglutide, sold under the brand names Ozempic, Wegovy and Rybelsus, is an antidiabetic medication used for the treatment of type 2 diabetes and an anti-obesity medication used for long-term weight management, developed by Novo Nordisk in 2012.Semaglutide is a GLP-1 receptor agonist, meaning that it mimics the action of the human incretin glucagon-like peptide-1 (GLP-1), thereby increasing insulin secretion and increasing blood sugar disposal and improving glycemic control.

Read more in the app

New Pill Form of Semaglutide Shows Major Benefits for People With Diabetes

Will Using Semaglutide Increase Your Risk of Thyroid Cancer?

Lifetime health effects and cost-effectiveness of tirzepatide and semaglutide in US adults - EurekAlert

Beyond Weight Loss: Semaglutide Could Curb Alcohol Cravings According to USC Study

Weight-loss jabs may help reduce alcohol intake, study finds - First clinical trial of its kind has found that semaglutide, distributed under the brand name Wegovy, cut the amount of alcohol people drank by about 40% and dramatically reduced people’s desire to drink.

Heart Shrinkage Linked to Popular Weight-Loss Drug Ozempic/Semaglutide

Insurance coverage, type of employment shape inequities in access to semaglutide - EurekAlert

Semaglutide can have lifetime cost and health - EurekAlert

Protecting Your Kidneys and More: Scientists Identify New Benefits of Semaglutide and Ozempic

Semaglutide may reduce opioid overdoses, a new study suggests

Does Semaglutide (Ozempic/Wegovy) Harm Your Mental Health? New Study Says No

Preventing Heart Attacks: Scientists Discover New Health Benefits of Semaglutide

Semaglutide: A Diet Drug Dilemma for Medicare With a $145 Billion Price Tag

Semaglutide leads to greater weight loss in women than men with HF and improves HF symptoms

Revolutionary Weight Loss: Largest Ever Obesity Study Showcases Semaglutide’s Promise

Beyond Weight Loss: Semaglutide Delivers Major Heart Health Benefits

Vanishing Fat: Semaglutide’s Triumph Over HIV Liver Disease

After treatment with semaglutide, newly diagnosed Type 1 diabetes patients needed little or no insulin

Higher doses of oral semaglutide improves blood sugar control and weight loss

Cutting Alcohol Consumption in Half – Scientists Discover Surprising Side Effect of Obesity Drug Semaglutide